Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Clinical trial NCT03201146 · UNKNOWN

Trial details

NCT number: NCT03201146
Sponsor: West China Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non Small Cell Lung Cancer Combination Chemotherapy Apatinib

Start date: 2017-06-27
Primary completion: 2020-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.